title: Pioglitazone may offer therapeutic advantages in diabetes-related atrial fibrillation.
authors: Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China. Electronic address: lcl1979_2001@yahoo.cn.
authors: Changle
authors: C
authors: Liu
authors: Tong
authors: T
authors: Liu
authors: Guangping
authors: G
authors: Li
mesh_terms: D001281:Atrial Fibrillation / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology*; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone
keywords: Atrial fibrillation; Diabetes mellitus; Pioglitazone